Abstract

HomeStrokeVol. 54, No. 3Antifibrinolytic Therapy for Aneurysmal Subarachnoid Hemorrhage: An Update of a Cochrane Systematic Review No AccessArticle CommentaryRequest AccessFull TextAboutView Full TextView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toNo AccessArticle CommentaryRequest AccessFull TextAntifibrinolytic Therapy for Aneurysmal Subarachnoid Hemorrhage: An Update of a Cochrane Systematic Review Menno R. Germans, MD, PhD, Wouter J. Dronkers, MD, LLM, MA, M. Irem Baharoglu, MD, PhD, René Post, MD, PhD, Dagmar Verbaan, PhD, Gabriël J.E. Rinkel, MD, PhD and Yvo B.W.E.M. Roos, MD, PhD Menno R. GermansMenno R. Germans Correspondence to: Menno R. Germans, MD PhD, Rämistrasse 100 (CAMPUS), Department of Neurosurgery, 8091 Zurich, Switzerland. Email E-mail Address: [email protected] https://orcid.org/0000-0003-2185-4526 Department of Neurosurgery (M.R.G.), University Hospital Zurich, Zurich, Switzerland. Clinical Neuroscience Center (M.R.G.), University Hospital Zurich, Zurich, Switzerland. Search for more papers by this author , Wouter J. DronkersWouter J. Dronkers Department of Neurosurgery (W.J.D., R.P., D.V.), Amsterdam UMC location University of Amsterdam, the Netherlands. Amsterdam Neuroscience, Neurovascular Disorders, the Netherlands (W.J.D., M.I.B., R.P., D.V., Y.B.W.E.M.R.). Search for more papers by this author , M. Irem BaharogluM. Irem Baharoglu Department of Neurology (M.I.B., Y.B.W.E.M.R.), Amsterdam UMC location University of Amsterdam, the Netherlands. Amsterdam Neuroscience, Neurovascular Disorders, the Netherlands (W.J.D., M.I.B., R.P., D.V., Y.B.W.E.M.R.). Search for more papers by this author , René PostRené Post https://orcid.org/0000-0001-7844-6262 Department of Neurosurgery (W.J.D., R.P., D.V.), Amsterdam UMC location University of Amsterdam, the Netherlands. Amsterdam Neuroscience, Neurovascular Disorders, the Netherlands (W.J.D., M.I.B., R.P., D.V., Y.B.W.E.M.R.). Search for more papers by this author , Dagmar VerbaanDagmar Verbaan https://orcid.org/0000-0002-9212-5470 Department of Neurosurgery (W.J.D., R.P., D.V.), Amsterdam UMC location University of Amsterdam, the Netherlands. Amsterdam Neuroscience, Neurovascular Disorders, the Netherlands (W.J.D., M.I.B., R.P., D.V., Y.B.W.E.M.R.). Search for more papers by this author , Gabriël J.E. RinkelGabriël J.E. Rinkel Department of Neurology and Neurosurgery, University Medical Center Utrecht, the Netherlands (G.J.E.R.) Search for more papers by this author and Yvo B.W.E.M. RoosYvo B.W.E.M. Roos https://orcid.org/0000-0001-9205-5882 Department of Neurology (M.I.B., Y.B.W.E.M.R.), Amsterdam UMC location University of Amsterdam, the Netherlands. Amsterdam Neuroscience, Neurovascular Disorders, the Netherlands (W.J.D., M.I.B., R.P., D.V., Y.B.W.E.M.R.). Search for more papers by this author Originally published27 Feb 2023https://doi.org/10.1161/STROKEAHA.122.041955Stroke. 2023;54:e91–e92"Antifibrinolytic Therapy for Aneurysmal Subarachnoid Hemorrhage: An Update of a Cochrane Systematic Review." Stroke, 54(3), pp. e91–e92FootnotesFor Sources of Funding and Disclosures, see page e92.Correspondence to: Menno R. Germans, MD PhD, Rämistrasse 100 (CAMPUS), Department of Neurosurgery, 8091 Zurich, Switzerland. Email Menno.[email protected]chReference1. Germans MR, Dronkers WJ, Baharoglu MI, Post R, Verbaan D, Rinkel GJE, Roos YBWEM. Antifibrinolytic therapy for aneurysmal subarachnoid hemorrhage. Cochrane Database Syst Rev. 2022; 11:CD001245. doi: 10.1002/14651858.CD001245.pub3CrossrefGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetails March 2023Vol 54, Issue 3 Advertisement Article InformationMetrics © 2023 American Heart Association, Inc.https://doi.org/10.1161/STROKEAHA.122.041955PMID: 36848425 Originally publishedFebruary 27, 2023 Keywordsantifibrinolytic agentsrandomized controlled trialaneurysmsubarachnoid hemorrhagehemorrhagerupturedPDF download Advertisement SubjectsCerebral AneurysmClinical StudiesIntracranial Hemorrhage

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.